Sphera Funds Management’s CARGO Therapeutics CRGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-179,674
Closed -$2.59M 119
2024
Q4
$2.59M Sell
179,674
-10,832
-6% -$197K 0.47% 68
2024
Q3
$3.51M Buy
190,506
+35,000
+23% +$626K 0.56% 53
2024
Q2
$2.55M Buy
155,506
+80,506
+107% +$1.53M 0.35% 79
2024
Q1
$1.67M Hold
75,000
0.24% 84
2023
Q4
$1.74M Buy
+75,000
New +$1.27M 0.28% 77

Other funds holding CRGX

Sphera Funds Management's CRGX Position: Q1 2025 in Review

Sphera Funds Management sold out of CARGO Therapeutics (CRGX) in Q1 2025, closing a stake of 179,674 shares — an estimated $2.59M sold.

Sphera Funds Management first reported a position in CRGX in Q4 2023 and held it in 5 quarters. The position peaked at $3.51M in Q3 2024. 113 funds tracked by Wall St. Rank hold CRGX as of Q1 2025.

  • Sphera Funds Management reported no remaining CARGO Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Sphera Funds Management sold 179,674 CARGO Therapeutics shares in Q1 2025, an estimated $2.59M.
  • Sphera Funds Management first reported a position in CARGO Therapeutics in Q4 2023 and held it in 5 quarters.
  • Sphera Funds Management's CARGO Therapeutics position peaked at $3.51M in Q3 2024.
  • 113 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2025.

Based on Sphera Funds Management's 13F filing for Q1 2025, filed 15 May 2025.